The Food and Drug Administration is turning to a widely condemned narcotic in an effort to help people dealing with post-traumatic stress disorder (PTSD). The FDA has classified the noted party drug as a “breakthrough therapy” for patients. The “breakthrough” designation isn’t just a ceremonial title. The FDA will now fast-track the review of ecstasy as an approved treatment for PTSD. The pills, known by drug dealers and users as “Molly,” reportedly contain the chemical MDMA, which researchers believe is a key in treating the disorder. According to reports, MDMA helps patients deal with traumatic memories by relieving some of...